Listed on GrantGunner. Last checked 16 Oct 2026.
About this grant
The Singapore Therapeutics Development Review (STDR) is a national-level grant call for public sector research, implemented by the Agency for Science, Technology and Research (A*STAR) in partnership with strategic partners including the Experimental Drug Development Centre (EDDC), Nucleic Acid Therapeutics Initiative (NATi) and Singapore-MIT Alliance for Research and Technology (SMART). The programme aims to boost the quality and quantity of drug development in Singapore.
Who can apply
Researchers at eligible Singapore institutions. A*STAR programs may have specific eligibility for Singapore-based researchers, research institutes, and industry partners.
More grants from Agency for Science, Technology and Research (A*STAR)